Peijia Medical forecasts H1 revenue RMB 415 million-RMB 435 million, up 17.4%-23.1%

PUBT · 1d ago
Peijia Medical forecasts H1 revenue RMB 415 million-RMB 435 million, up 17.4%-23.1%
  • Peijia Medical flagged unaudited revenue of RMB 415-435 million for the six months ended June 30, 2026, up 17.4%-23.1% from RMB 353.4 million.
  • Total TAVR implantations reached about 2,830 units, up about 36.5% from the prior-year period.
  • TAVR hospital coverage exceeded 850 across Greater China, up about 70 from Dec. 31, 2025.
  • TaurusTrio implantations topped 660 units in mainland China during the period.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Peijia Medical Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260807-12277632), on August 07, 2026, and is solely responsible for the information contained therein.